ClinicalTrials.gg
DrugCombination product

Selatogrel clinical trials

Also written ACT-246475.

Its developmentBy Viatris and Idorsia Pharmaceuticals, step by step11 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.
studies test it
11
open now
1
in phase 3
1
first study started
2011

How each study uses selatogrel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the selatogrel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Selatogrel
7

Development codes

ACT-246475
9
ACT-246575
1

Studies by the year they started

11 studies that test it; most in 2018 (4)

Studies that test selatogrel, by start year
YearStudies
20111
20184
20191
20202
20211
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
2
Phase 3
1

Who runs them

Industry 11 · Other 0

Viatris Innovation GmbH (10) · Idorsia Pharmaceuticals Ltd. (1)

Often tested with

Tested in the same studies.

Clopidogrel (1) · Prasugrel (1) · Ticagrelor (1) · ACT-281959 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test selatogrel, phase 3 first.

Studies

Open first, then newest update. How each study uses selatogrel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Codes

What other systems call selatogrel · ClinicalTrials.gg INT000311

  • MeSH (NLM) C000601315selatogrelConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 6DPK7O4PR7SELATOGRELConfirmed FDA, NLM, Wikidata
  • Wikidata Q76754380selatogrelConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166930SelatogrelOne source FDA
  • DrugBank DB15163One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.